FIELD: medicine. SUBSTANCE: vaccine has living spores of noncapsule strain of Bac. anthracis СТИ and protective antigen of Bac. anthracis. A single dose of commercial variant of vaccine has: living spores of strain Bac. anthracis СТИ - 40-60 mln; protective antigen of Bac. anthracis - 30-40 ИД50 and aluminium hydroxide gel 2.5 mg, not above, where ИД50 - mean effective immunizing unit for albino mice. Vaccination is carried out one time per a year, expressing immunity is formed in 7-10 days. Immunization at antibiotic therapy background is possible. EFFECT: improved quality of vaccine. 5 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD TO OBTAIN DRY COMBINED ANTHRAX VACCINE | 1999 |
|
RU2181294C2 |
METHOD FOR COMPLEX PROPHYLAXIS OF ANTHRAX | 2002 |
|
RU2216349C1 |
DNA-STRUCTURE ENCODING MODIFIED VERSION OF PROTECTIVE ANTIGENE BACILLUS ANTHRACIS | 2015 |
|
RU2622085C2 |
TEST-INFECTING CULTURE IN ASSAY OF IMMUNOGENICITY OF ANTHRAX VACCINES, EFFECTIVENESS OF AGENTS FOR EMERGENCY PROPHYLAXIS AND TREATMENT OF PATIENTS WITH ANTHRAX | 1997 |
|
RU2141522C1 |
ORAL METHOD OF ANTHRAX VACCINE PROPHYLAXIS | 2018 |
|
RU2712133C1 |
ANTHRAX VACCINE STRAIN STI-PR-4 WITH BROADENED SPECTRUM OF RESISTANCE TO ANTIBIOTICS | 2000 |
|
RU2173342C1 |
METHOD OF SELECTION OF IMMUNOGENIC STRAINS AND SUBCULTURES OF LIVE ANTHRAX VACCINES | 1995 |
|
RU2101355C1 |
ATTENUATED STRAIN Bacillus anthracis FOR DEVELOPING MEANS OF SPECIFIC PREVENTION OF ANTHRAX | 2013 |
|
RU2544951C1 |
VACCINE AGAINST ANTHRAX AND EMPHYSEMATOUS CARBUNCLE ALIVE ASSOCIATED AND METHOD FOR PROPHYLAXIS AGAINST THESE DISEASES | 1994 |
|
RU2112544C1 |
LIVE ANTHRAX VACCINE FOR GOATS | 2022 |
|
RU2802204C2 |
Authors
Dates
1998-07-20—Published
1992-08-28—Filed